Pertuzumab and trastuzumab plus standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: Efficacy analysis of a phase II cardiac safety study (TRYPHAENA)
Authors: Schneeweiss, A., Chia, S., Hickish, T., Harvey, V., Eniu, A., Waldron-Lynch, M., Eng-Wong, J., Kirk, S., Cortes, J.
Journal: CANCER RESEARCH
Publication Date: 02/2017
Volume: 77
eISSN: 1538-7445
ISSN: 0008-5472
DOI: 10.1158/1538-7445.SABCS16-P4-21-02
Source: Web of Science